ACADIA PHARMACEUTICALS INC (ACAD) Stock Income Statement
NASDAQ:ACAD - Nasdaq - US0042251084 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 957.80M | 726.44M | 517.20M | 484.10M | 441.80M | |||
| Cost Of Goods | 81.84M | 41.64M | 10.20M | 18.00M | 20.60M | |||
| Gross Profit | 875.96M | 684.80M | 507.10M | 466.10M | 421.20M | |||
| Operating Expenses | 791.68M | 758.18M | 730.60M | 636.60M | 707.70M | |||
| Research and Development | 303.25M | 351.62M | 361.60M | 239.40M | 319.10M | |||
| Selling, General, and Administrative Expenses | 488.43M | 406.56M | 369.10M | 396.00M | 388.70M | |||
| Operating Income | 84.28M | -73.38M | -223.60M | -170.40M | -286.60M | |||
| Interest Income/Expense | 25.46M | 17.23M | 6.60M | 600.00K | 6.60M | |||
| Other Income/Expense | 1.82M | 5.11M | 3.50M | 2.30M | -1.00M | |||
| Non Recurring Items | 146.51M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | 258.07M | -51.04M | -213.40M | -167.50M | -281.00M | |||
| Income Tax | 31.62M | 10.25M | 2.50M | 400.00K | 600.00K | |||
| Net Income | 226.45M | -61.29M | -216.00M | -167.90M | -281.60M | |||
| EBITDA | 100.16M | -67.83M | -221.57M | -167.05M | -283.66M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.36 | -0.37 | -1.34 | -1.05 | -1.79 | |||
| Non GAAP EPS | 0.48 | -0.38 | -0.97 | -1.05 | -1.80 | |||
| Statistics | ||||||||
| Gross Profit Margin | 91.46% | 94.27% | 98.05% | 96.28% | 95.34% | |||
| Profit Margin | 23.64% | -8.44% | -41.76% | -34.68% | -63.74% | |||
| Operating Profit Margin | 8.80% | -10.10% | -43.23% | -35.20% | -64.87% | |||
All data in USD